Literature DB >> 12154531

Measuring hepatitis B uptake in a new universal infant program.

Meenakshi Dawar1, Simon Dobson, Arlene Kallos, Carol LaJeunesse, Shelagh Weatherill, Patricia Daly.   

Abstract

BACKGROUND: Vancouver-Richmond Health Board has the highest reported rate of hepatitis B in Canada, including an annual average of 25 cases in children under 12 years of age, based on reports from 1994-1997 inclusive. The current provincial adolescent grade-six hepatitis B immunization program does not protect against childhood infection. The regional health board implemented universal infant hepatitis B immunization in September 1998.
METHOD: Immunization coverage data were obtained on a random sample of 191 infants born in March 1999 one year after initiation of the program.
RESULTS: By eight months of age, 97.9% of children had received some vaccinations. 73.8% of infants had received three doses of hepatitis B vaccine and 12.6% had received two doses. In comparison, 89% had received three doses and 7.9% two doses of DPTP-Hib vaccine. 13.1% of infants had not received any hepatitis B vaccine. For a majority (67%) of these children, their physician's lack of awareness or lack of acceptance of the program constituted the reason for no hepatitis B vaccine uptake. Only one parent cited adverse publicity as the reason for refusing vaccination.
INTERPRETATION: This survey reveals a successful first year of the program without harm to the pre-existing childhood vaccination programs. Hepatitis B vaccine uptake can be improved by increased awareness among physicians and parents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12154531

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  1 in total

1.  Immunization delivery in British Columbia: perspectives of primary care physicians.

Authors:  John Omura; Jane Buxton; Janusz Kaczorowski; Jason Catterson; Jane Li; Andrea Derban; Paul Hasselback; Shelagh Machin; Michelle Linekin; Tamsin Morgana; Barra O'Briain; David Scheifele; Meena Dawar
Journal:  Can Fam Physician       Date:  2014-03       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.